In our previous researches, we have reported the prognostic characteristics of LMP1 in lymphoma and have generated an anti-LMP1 Fab antibody (LMP1-Fab), exerting potential anti-tumor activity in nasopharyngeal carcinoma (NPC) [13–18]. The gene discussed is PDLIM7; the disease is lymphoma.